CNBX Pharmaceuticals Inc. (CNBX)

Market Cap	160.58K -27.5%
Revenue (ttm)	n/a
Net Income	-462.09K
EPS	-0.00
Shares Out	1.61B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,732,879
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.000001 - 0.0007
Beta	0.76
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 30, 2026

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc., a clinical-stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the local treatment of lateral spreading, or sessile, colorectal polyps during colonoscopy, BRST-33 for the treatment...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: CNBX

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 9, 2026

Data Sources Report a data error